Emma Guttman, MD, PhD Email Emma Guttman
- PROFESSOR AND SYSTEM CHAIR | Dermatology
- PROFESSOR | Medicine, Clinical Immunology
- Hospital Affiliations
- Mount Sinai Morningside and Mount Sinai West
- Mount Sinai Beth Israel
- Mount Sinai Queens
- New York Eye and Ear Infirmary of Mount Sinai
- The Mount Sinai Hospital
- Mount Sinai Brooklyn
- Mount Sinai Doctors East 98th Street 212-241-9728 212-241-9728
Emma Guttman-Yassky, MD, PhD is the Waldman Professor and System Chair of Dermatology and Immunology at the Icahn School of Medicine at Mount Sinai in New York City. She is the Director of the Center for Excellence in Eczema and the Occupational Dermatitis Clinic and Director of the Laboratory for Inflammatory Skin Diseases. She earned her MD degree from Sackler School of Medicine at the Tel-Aviv University, and a PhD degree from the Bar-Ilan University, Israel. After obtaining her Israeli Board certification in dermatology at Rambam Medical Center/Technion, Israel, Dr. Guttman moved to the U.S. to pursue a two-year postdoctoral fellowship at The Rockefeller University in the Laboratory for Investigative Dermatology. Upon completion of her fellowship, she became board-certified by the American Board of dermatology after a second dermatology residency training at the Weill-Cornell Medical College, in NY. Dr. Guttman’s major clinical and research focus areas are atopic dermatitis (AD)/eczema and alopecia areata. Her research made paradigm-shifting discoveries on the immunologic basis of atopic dermatitis (AD)/eczema in adults and children with atopic dermatitis, enriching the understanding of the pathophysiology of this common disorder, opening the door and accelerating testing of novel immune, pathway-specific drugs in this disease. She is now testing (both clinically and mechanistically) multiple targeted therapeutics for atopic dermatitis that target Th2, Th22, and Th17/IL-23 axis. Recently Dr. Guttman also extended her research interest to hair loss disorders such as alopecia areata and scarring hair loss disorders, chronic hand eczema, keloids, ichtyosis, and other skin diseases, in which her findings are also translated to novel therapeutic targets.
Dr. Guttman is considered one of the world’s leading experts in inflammatory skin diseases. Her achievements have been repeatedly highlighted by the media including the New York Times, ABC News, CBS News, Daily News, Reuters, Wall Street Journal, NY1, and others.
Dr. Guttman divides her time between a busy clinic, where she sees patients from all over the US and the world, that are coming to seek her advise in treating inflammatory skin diseases, and her growing laboratory that focuses on research on the mechanisms underlying inflammatory skin diseases, leading to novel treatments for these patients.
She co-founded the International Eczema Council (IEC), for which she functions as president since early 2018. Dr. Guttman received many national and international awards, including the American Academy of Allergy and Clinical Immunology (AAAAI) Award for Scientific Innovation, American Academy of Dermatology Young Investigator awards, and others. She was elected as a member to the American Society for Clinical Investigation (ASCI), as well as the American Dermatological Society (ADA). Dr. Guttman is often invited as a keynote speakerto international and national meetings, and authored ~240 peer-reviewed publications. Dr. Guttman is also the co-organizer of the Inflammatory Skin Disease Summit, that is considered one of the most successful meetings in dermatology.
American Board of Dermatology
- Allergy Testing
- Alopecia Areata
- Atopic Dermatitis
- Contact Dermatitis
- Skin Biopsy
Multi-Disciplinary Training Area
MD, Sackler School of Medicine
Rambam Health Care Campus
Internship, Internal Medicine
Memorial Sloan-Kettering Cancer Center
Weill Cornell Medical College
English, Hebrew, Romanian, Russian, Spanish
Young Investigator Award (2011)
American Academy of Dermatology
For groundbreaking research in atopic dermatitis with therapeutic implications
Inflammatory Skin Diseases
Dr. Guttman’s groundbreaking research focuses on atopic dermatitis/eczema and contact dermatitis. Her research has important implications in advancing the current molecular knowledge on atopic dermatitis/eczema and developing new therapeutics.
Dr. Guttman currently develops biomarkers of atopic dermatitis that could be used for future studies with targeted therapeutics. She also concentrates on unraveling the primary pathogenesis of this common disease.
She is the recipient of the prestigious Young Investigator Award (2011) from the of Dermatology, the 2011 recipient of the Dermatology Foundation’s Physician-Scientist Career Development Award, and the recipient of the Fisher award of the American Contact Dermatitis Society 2011.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Below are financial relationships with industry reported by Dr. Guttman during 2020 and/or 2021. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
- AbbVie Inc.
- Aditum Bio
- Almirall, S.A.
- Amgen Inc.
- Arena Pharmaceuticals, Inc.
- Boehringer Ingelheim Corporation
- Boston Pharmaceuticals Inc.
- Bristol-Myers Squibb
- Cara Therapeutics
- Celgene Corporation
- DBV Technologies
- EMD Serono, Inc. (Merck & Co., Inc.)
- Eli Lilly and Company
- Galderma S.A.
- Ichnos Sciences
- Janssen Pharmaceuticals, Inc.
- Kyowa Kirin Co., Ltd.
- LEO Pharma A/S
- Larrk bi
- Novartis Pharma AG
- Pfizer Inc.
- Principia Biopharma
- Regeneron Pharmaceuticals
- SATO Pharmaceutical
- Seanergy Dermatology
- Seelos Therapeutics
- Serpin Pharma
- Sonoma Biosciences
- Vanda Pharmaceuticals, Inc.
- Ventyx Biosciences
- Vimalan Biosciences
Scientific Advisory Board:
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.